* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 6198 | RPS6KB1 | C0079744 | Diffuse Large B-Cell Lymphoma | 0.200549453568426 | BEFREE;CTD_human |
| 6198 | RPS6KB1 | C0020538 | Hypertensive disease | 0.2 | CTD_human |
| 6198 | RPS6KB1 | C0149721 | Left Ventricular Hypertrophy | 0.2 | CTD_human |
| 6198 | RPS6KB1 | C0333641 | Atrophic | 0.2 | CTD_human |
| 6198 | RPS6KB1 | C2931673 | Ceroid lipofuscinosis, neuronal 1, infantile | 0.2 | CTD_human |
| 6198 | RPS6KB1 | C0919267 | ovarian neoplasm | 0.010931649859255 | LHGDN |
| 6198 | RPS6KB1 | C1458155 | Mammary Neoplasms | 0.0060152784980537 | BEFREE;LHGDN |
| 6198 | RPS6KB1 | C0041341 | Tuberous Sclerosis | 0.00355709281745305 | BEFREE;LHGDN |
| 6198 | RPS6KB1 | C0006142 | Malignant neoplasm of breast | 0.0032967214105572 | BEFREE |
| 6198 | RPS6KB1 | C0002395 | Alzheimer's Disease | 0.00328236603323995 | BEFREE;LHGDN |
| 6198 | RPS6KB1 | C0678222 | Breast Carcinoma | 0.0030219946263441 | BEFREE |
| 6198 | RPS6KB1 | C2239176 | Liver carcinoma | 0.00300763924902685 | BEFREE;LHGDN |
| 6198 | RPS6KB1 | C0017636 | Glioblastoma | 0.00273291246481375 | LHGDN |
| 6198 | RPS6KB1 | C0023473 | Myeloid Leukemia, Chronic | 0.00273291246481375 | LHGDN |
| 6198 | RPS6KB1 | C0023903 | Liver neoplasms | 0.00273291246481375 | LHGDN |
| 6198 | RPS6KB1 | C0024121 | Lung Neoplasms | 0.00273291246481375 | LHGDN |
| 6198 | RPS6KB1 | C0036220 | Kaposi Sarcoma | 0.00273291246481375 | LHGDN |
| 6198 | RPS6KB1 | C0009375 | Colonic Neoplasms | 0.002407028523288 | GAD |
| 6198 | RPS6KB1 | C0018671 | Head and Neck Neoplasms | 0.002407028523288 | GAD |
| 6198 | RPS6KB1 | C0027643 | Neoplasm Recurrence, Local | 0.002407028523288 | GAD |
| 6198 | RPS6KB1 | C0034885 | Rectal Neoplasms | 0.002407028523288 | GAD |
| 6198 | RPS6KB1 | C0085183 | Neoplasms, Second Primary | 0.002407028523288 | GAD |
| 6198 | RPS6KB1 | C0028754 | Obesity | 0.0013736339210655 | BEFREE |
| 6198 | RPS6KB1 | C0596263 | Carcinogenesis | 0.0013736339210655 | BEFREE |
| 6198 | RPS6KB1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0010989071368524 | BEFREE |
| 6198 | RPS6KB1 | C0376358 | Malignant neoplasm of prostate | 0.0010989071368524 | BEFREE |
| 6198 | RPS6KB1 | C0600139 | Prostate carcinoma | 0.0010989071368524 | BEFREE |
| 6198 | RPS6KB1 | C0029925 | Ovarian Carcinoma | 0.0008241803526393 | BEFREE |
| 6198 | RPS6KB1 | C1140680 | Malignant neoplasm of ovary | 0.0008241803526393 | BEFREE |
| 6198 | RPS6KB1 | C1519670 | Tumor Angiogenesis | 0.0008241803526393 | BEFREE |
| 6198 | RPS6KB1 | C0005684 | Malignant neoplasm of urinary bladder | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0005695 | Bladder Neoplasm | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0031511 | Pheochromocytoma | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0235974 | Pancreatic carcinoma | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0332996 | Persistent embryonic structure | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0346647 | Malignant neoplasm of pancreas | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0424295 | Hyperactive behavior | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0699885 | Carcinoma of bladder | 0.0005494535684262 | BEFREE |
| 6198 | RPS6KB1 | C0003872 | Arthritis, Psoriatic | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0007138 | Carcinoma, Transitional Cell | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0007222 | Cardiovascular Diseases | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0009241 | Cognition Disorders | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0014859 | Esophageal Neoplasms | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0016667 | Fragile X Syndrome | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0017638 | Glioma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0023418 | leukemia | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0023462 | Acute Megakaryocytic Leukemias | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0025149 | Medulloblastoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0025286 | Meningioma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0025517 | Metabolic Diseases | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0026769 | Multiple Sclerosis | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0027819 | Neuroblastoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0028756 | Obesity, Morbid | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0030421 | Paraganglioma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0033578 | Prostatic Neoplasms | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0036690 | Septicemia | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0042900 | Vitiligo | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0152018 | Esophageal carcinoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0175754 | Agenesis of corpus callosum | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0178874 | Tumor Progression | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0206667 | Adrenal Cortical Adenoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0220620 | Gastrointestinal Carcinoid Tumor | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0233794 | Memory impairment | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0243026 | Sepsis | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0268281 | Infantile neuronal ceroid lipofuscinosis | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0271650 | Impaired glucose tolerance | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0279628 | Adenocarcinoma Of Esophagus | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0282160 | Aplasia Cutis Congenita | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0338656 | Impaired cognition | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0346990 | Carcinomatosis of peritoneal cavity | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0392514 | Hereditary hemochromatosis | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0524851 | Neurodegenerative Disorders | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0546837 | Malignant neoplasm of esophagus | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0699790 | Colon Carcinoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0700095 | Central neuroblastoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0751291 | Desmoplastic Medulloblastoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0751674 | Lymphangioleiomyomatosis | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C0856169 | Endothelial dysfunction | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C1275122 | Familial multiple trichoepitheliomata | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C1512127 | HER2 gene amplification | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C1527390 | Neoplasms, Intracranial | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C1621958 | Glioblastoma Multiforme | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C2145472 | Urothelial Carcinoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C2986665 | Early-Stage Breast Carcinoma | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C3539878 | Triple Negative Breast Neoplasms | 0.0002747267842131 | BEFREE |
| 6198 | RPS6KB1 | C3887505 | DYSFUNCTION - SKIN DISORDERS | 0.0002747267842131 | BEFREE |